资讯

The brain is one of the body’s most energy-demanding organs, accounting for 2 percent of the body’s weight but consuming 20 ...
First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively ...
The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...
Our educational programs advance Harvard Medical School's core mission to alleviate human suffering by nurturing a diverse group of leaders and future leaders in both clinical care and biomedical ...
The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer… ...
Paul F. Glenn Center for Biology of Aging Research is dedicated to understanding the mechanisms of normal aging and the development of interventions to delay its onset and progression, thereby ...
Joel Habener wins 2025 Breakthrough Prize in Life SciencesApril 7, 2025 ...
Our researchers – based at the School and its 15 affiliated hospitals – generate knowledge that transforms the way we treat patients, by producing life-changing new medicines, devices, and ...
Although it can’t compose poetry or solve equations, this extensive network uses the same chemicals and cells as the brain to help us digest and to alert the brain when something is amiss. Gut and ...
In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long endeavor reached fruition in the form of a new treatment, CASGEVY, approved by ...
New AI model identifies possible therapies from existing medicines for thousands of diseases, including rare ones with no current treatments. The AI tool generates new insights on its own, applies ...